Search filters

List of works by Michael Wang

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity

scientific article published on 06 July 2020

Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.

scientific article published on 8 December 2017

Optimal trough levels in haemophilia B: Raising expectations

scientific article published on 25 August 2020

Outcome measures in Haemophilia: Beyond ABR (Annualized Bleeding Rate)

scientific article published on 04 January 2021

PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding.

scientific article published on 3 August 2017

Real-world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years

scientific article published on 04 October 2020

Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysis

scientific article published on 18 November 2020

Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.

scientific article published on 5 October 2017

Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.

scientific article published on 16 April 2017

von Willebrand disease Outreach into Integrated Care Education (VOICE): a call to action.

scientific article published on 26 May 2017